Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets

[1]  O. Ostrovsky,et al.  Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer? , 2021, Biomolecules.

[2]  C. Plass,et al.  Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation , 2021, Genome medicine.

[3]  E. Yahya,et al.  Recent trends in cancer therapy: A review on the current state of gene delivery. , 2021, Life sciences.

[4]  Sakhawat Ali,et al.  An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression , 2021, Cancer and Metastasis Reviews.

[5]  D. D. De Carvalho,et al.  Clinical advances in targeting epigenetics for cancer therapy , 2021, The FEBS journal.

[6]  C. Mian,et al.  Epigenetic in medullary thyroid cancer: the role of microRNA in tumorigenesis and prognosis , 2020, Current opinion in oncology.

[7]  F. Zal,et al.  Effect of folic acid and vitamin E on promoter DNA methylation and expression of TGF-β1, ESR-1 and CDH-1 in the uterus of STZ-induced diabetic rats , 2020, Archives of physiology and biochemistry.

[8]  D. Schuppan,et al.  Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity. , 2020, The Journal of clinical endocrinology and metabolism.

[9]  Yao Zhang,et al.  Mathematical modelling of the role of GADD45β in the pathogenesis of multiple myeloma , 2020, Royal Society Open Science.

[10]  C. Riccardi,et al.  Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells. , 2020, Biochimica et biophysica acta. Gene regulatory mechanisms.

[11]  Yuan Li,et al.  De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties. , 2019, Experimental cell research.

[12]  Yuri Kim,et al.  Effects of β-carotene on Expression of Selected MicroRNAs, Histone Acetylation, and DNA Methylation in Colon Cancer Stem Cells , 2019, Journal of cancer prevention.

[13]  F. Schumacher,et al.  Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells , 2019, Epigenetics.

[14]  S. Chuang,et al.  Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan , 2019, Marine drugs.

[15]  P. Tassone,et al.  Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma , 2019, Cancers.

[16]  J. Lozano-Sánchez,et al.  An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors , 2018, Carcinogenesis.

[17]  Hao Wu,et al.  Peperomin E Induces Promoter Hypomethylation of Metastatic-Suppressor Genes and Attenuates Metastasis in Poorly Differentiated Gastric Cancer , 2018, Cellular Physiology and Biochemistry.

[18]  F. Schumacher,et al.  Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells , 2018, Oncotarget.

[19]  Subhayan Sur,et al.  Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line , 2018, Journal of cellular physiology.

[20]  T. Tollefsbol,et al.  Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic–Mediating Machinery , 2018, International journal of molecular sciences.

[21]  T. Tollefsbol,et al.  Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms , 2018, Experimental cell research.

[22]  S. Katiyar,et al.  Abstract 1390: Honokiol, a bioactive component fromMagnoliaplant, promotes DNA demethylation and reactivates silenced tumor suppressors in pancreatic cancer cells through TET-dependent mechanism , 2018, Molecular and Cellular Biology / Genetics.

[23]  C. Riccardi,et al.  Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1‐dependent mechanism , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Shenglin Ma,et al.  S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 , 2018, Journal of Ovarian Research.

[25]  M. M. Sarabi,et al.  The impact of polyunsaturated fatty acids on DNA methylation and expression of DNMTs in human colorectal cancer cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  K. Wagner,et al.  Counteraction of Oxidative Stress by Vitamin E Affects Epigenetic Regulation by Increasing Global Methylation and Gene Expression of MLH1 and DNMT1 Dose Dependently in Caco-2 Cells , 2018, Oxidative medicine and cellular longevity.

[27]  F. Zheng,et al.  HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. , 2018, Biochimica et biophysica acta. General subjects.

[28]  Renyi Wu,et al.  Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells , 2018, The AAPS Journal.

[29]  J. Lozano-Sánchez,et al.  Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells , 2018, Carcinogenesis.

[30]  Wenjun Zhou,et al.  Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[31]  Annisa Muthiah Sukirman Molecular Docking Study of Lycopene on Reducing the DNA-methyltransfer in Prostate Cancer , 2018 .

[32]  Lijian Zhang,et al.  The anticancer role of omega-3 polyunsaturated fatty acids was closely associated with the increase of genomic DNA hydroxymethylation. , 2018, Anti-cancer agents in medicinal chemistry.

[33]  K. Alimoghaddam,et al.  Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4) , 2018, Annals of Hematology.

[34]  S. Lorenz,et al.  Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes , 2017, Molecular Cancer.

[35]  Leila Mohammadi Amirabad,et al.  L-Ascorbic acid affect the DNA methytransferase expression in Mouse Embryonic Fibroblasts , 2017 .

[36]  K. Brinkrolf,et al.  Integrative analysis of DNA methylation and gene expression in butyrate-treated CHO cells. , 2017, Journal of biotechnology.

[37]  M. Lai,et al.  Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer , 2017, Oncology letters.

[38]  A. Verma,et al.  Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells , 2017, Blood Cancer Journal.

[39]  Cuiping Liu,et al.  Inositol hexaphosphate suppresses colorectal cancer cell proliferation via the Akt/GSK‐3&bgr;/&bgr;‐catenin signaling cascade in a 1,2‐dimethylhydrazine‐induced rat model , 2017, European journal of pharmacology.

[40]  S. Katiyar,et al.  Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin , 2017, Scientific Reports.

[41]  W. V. Berghe,et al.  Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A , 2017, Oncotarget.

[42]  Yong-wei Hu,et al.  p-Akt as a potential poor prognostic factor for gastric cancer: A systematic review and meta-analysis. , 2017, Oncotarget.

[43]  M. Lai,et al.  Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer , 2017, Oncology letters.

[44]  A. Kong,et al.  Methylation of the Promoter and Reactivation of the Expression of GSTP 1 by Astaxanthin in Human Prostate LNCaP Cells , 2016 .

[45]  M. Momeny,et al.  Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells. , 2016, Life sciences.

[46]  R. Liu,et al.  Peperomin E reactivates silenced tumor suppressor genes in lung cancer cells by inhibition of DNA methyltransferase , 2016, Cancer science.

[47]  K. Trtkova,et al.  Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine. , 2016, Oncology reports.

[48]  F. Zheng,et al.  Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I , 2016, Journal of experimental & clinical cancer research : CR.

[49]  Dong Li,et al.  Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology , 2016, Nanoscale Research Letters.

[50]  N. Mikirova,et al.  Gene expression response to ascorbic acid in mice implanted with sarcoma S180 cells , 2016 .

[51]  S. Cai,et al.  The Effect of Decitabine Combined with Arsenic Trioxide on DAPK Gene and HL-60 Cell Proliferation and Apoptosis , 2015 .

[52]  Yong Cai,et al.  Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells , 2015, PloS one.

[53]  P. Hwang,et al.  Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells , 2015, Marine drugs.

[54]  Yuan Li,et al.  Induction of the mesenchymal to epithelial transition by demethylation‐ activated microRNA‐200c is involved in the anti‐migration/invasion effects of arsenic trioxide on human breast cancer cells , 2015, Molecular carcinogenesis.

[55]  S. Patra,et al.  Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer. , 2015, Chemico-biological interactions.

[56]  M. Nagarkatti,et al.  Δ9‐Tetrahydrocannabinol‐mediated epigenetic modifications elicit myeloid‐derived suppressor cell activation via STAT3/S100A8 , 2015, Journal of leukocyte biology.

[57]  G. Sung,et al.  Quercetin-induced apoptosis prevents EBV infection , 2015, Oncotarget.

[58]  Jianping Chen,et al.  Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation , 2015, Oncotarget.

[59]  Jianping Zhang,et al.  Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer , 2014, Cancer science.

[60]  Q. Qu,et al.  The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP , 2014, International journal of endocrinology.

[61]  Ling Wang,et al.  Blocking of JB6 Cell Transformation by Tanshinone IIA: Epigenetic Reactivation of Nrf2 Antioxidative Stress Pathway , 2014, The AAPS Journal.

[62]  Soonkyu Chung,et al.  Ellagic acid inhibits adipocyte differentiation through coactivator-associated arginine methyltransferase 1-mediated chromatin modification. , 2014, The Journal of nutritional biochemistry.

[63]  C. Busch,et al.  Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells , 2014, Front. Oncol..

[64]  Wen-Yu Wu,et al.  Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor suppressor genes p21 and p16 in a Tet-dependent DNA demethylation manner in human skin cancer cells. , 2014, Cancer biotherapy & radiopharmaceuticals.

[65]  K. Gupta,et al.  Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. , 2014, Toxicology and applied pharmacology.

[66]  Yan Wang,et al.  Arsenic Trioxide Inhibits DNA Methyltransferase and Restores TMS1 Gene Expression in K562 Cells , 2014, Acta Haematologica.

[67]  T. Tollefsbol,et al.  Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate. , 2014, Experimental cell research.

[68]  X. Niu,et al.  TLR2-ICAM1-Gadd45α Axis Mediates the Epigenetic Effect of Selenium on DNA Methylation and Gene Expression in Keshan Disease , 2014, Biological Trace Element Research.

[69]  R. Carroll,et al.  Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation , 2014, Experimental biology and medicine.

[70]  W. V. Berghe,et al.  Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells , 2014, PloS one.

[71]  R. Wolff,et al.  Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: The breast cancer health disparities study , 2014, International journal of cancer.

[72]  Jing-lan Wu,et al.  Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-κB signaling. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[73]  S. Katiyar,et al.  Prostaglandin E2 Promotes UV radiation-induced immune suppression through DNA hypermethylation. , 2013, Neoplasia.

[74]  K. Kang,et al.  The role of a ginseng saponin metabolite as a DNA methyltransferase inhibitor in colorectal cancer cells. , 2013, International journal of oncology.

[75]  R. Woodman,et al.  Combination of Selenium and Green Tea Improves the Efficacy of Chemoprevention in a Rat Colorectal Cancer Model by Modulating Genetic and Epigenetic Biomarkers , 2013, PloS one.

[76]  V. Cardile,et al.  Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines. , 2013, Current pharmaceutical design.

[77]  S. Mirza,et al.  Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins , 2013, Journal of breast cancer.

[78]  Katarzyna Lubecka-Pietruszewska,et al.  Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. , 2013, Biochemical and biophysical research communications.

[79]  Xinru Wang,et al.  Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer , 2012, PloS one.

[80]  A. Bednarek,et al.  Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. , 2012, The British journal of nutrition.

[81]  Sun-Hee Kim,et al.  Prostaglandin E2 promotes intestinal tumor growth via DNA methylation , 2011, Nature Medicine.

[82]  J. Ellinger,et al.  Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. , 2011, Biochemical and biophysical research communications.

[83]  Jianhua Yang,et al.  Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo. , 2011, Oncology reports.

[84]  E. Olson,et al.  Histone Deacetylase 9 Is a Negative Regulator of Adipogenic Differentiation* , 2011, The Journal of Biological Chemistry.

[85]  K. Gupta,et al.  Epigenetics, an Early Event in the Modulation of Gene Expression by Inositol Hexaphosphate in Ethylnitrosourea Exposed Mouse Lungs , 2010, Nutrition and cancer.

[86]  Jan-Gowth Chang,et al.  Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells , 2011, BMC Cancer.

[87]  A. Bednarek,et al.  Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. , 2010, European journal of pharmacology.

[88]  V. Krajka-Kuźniak,et al.  The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. , 2010, Toxicology Letters.

[89]  Chun-Yan Peng,et al.  Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines , 2010, Leukemia & lymphoma.

[90]  K. Yelekçi,et al.  Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. , 2009, Bioorganic & medicinal chemistry.

[91]  P. Cartron,et al.  Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation , 2009, Clinical Cancer Research.

[92]  Xu Ma,et al.  Nordihydroguaiaretic acid restores expression of silenced E-cadherin gene in human breast cancer cell lines and xenografts , 2008, Anti-cancer drugs.

[93]  Hui Zhang,et al.  Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter , 2008, Molecular and Cellular Biology.

[94]  Xu Ma,et al.  Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. , 2008, Life sciences.

[95]  C. Klein,et al.  Modulation of gene methylation by genistein or lycopene in breast cancer cells , 2008, Environmental and molecular mutagenesis.

[96]  Lijun Xue,et al.  A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells. , 2007, Anticancer research.

[97]  K. Hatakeyama,et al.  Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. , 2006, Human pathology.

[98]  B. Zhu,et al.  Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. , 2006, Carcinogenesis.

[99]  R. Momparler,et al.  Synergistic antineoplastic action of DNA methylation inhibitor 5‐AZA‐2′‐deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells , 2003, International journal of cancer.